The Global Circulating Tumor Cells Market was Valued at US$ 9.5 Billion in 2023 and is Projected to Surpass the Market Size of US$ 19.0 Billion by 2032 at a CAGR of 8.06% During the Forecast Period 2024-2032 | Astute Analytica

The global 𝐜𝐢𝐫𝐜𝐮𝐥𝐚𝐭𝐢𝐧𝐠 𝐭𝐮𝐦𝐨𝐫 𝐜𝐞𝐥𝐥𝐬 (𝐂𝐓𝐂𝐬) 𝐦𝐚𝐫𝐤𝐞𝐭 is experiencing significant growth, driven by advancements in cancer diagnostics and increasing demand for non-invasive liquid biopsy techniques. In 𝟐𝟎𝟐𝟑, the market was valued at 𝐔𝐒$ 𝟗.𝟓 𝐛𝐢𝐥𝐥𝐢𝐨𝐧, and it is projected to reach a market size of 𝐔𝐒$ 𝟏𝟗.𝟎 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐, expanding at a robust compound annual growth rate (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟖.𝟎𝟔% during the forecast period of 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟐.

𝐓𝐡𝐞 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞- https://www.astuteanalytica.com/request-sample/circulating-tumor-cells-market

Circulating tumor cells are cancer cells that break away from the primary tumor and circulate in the bloodstream, potentially leading to the formation of new tumors (metastasis). Monitoring and analyzing CTCs offer valuable insights into cancer progression, providing opportunities for early diagnosis and personalized treatment plans. The increasing prevalence of cancer worldwide and the growing focus on precision medicine are major factors contributing to the rising demand for CTC-based diagnostics and therapeutics.

Technological advancements in CTC isolation, detection, and characterization techniques have further propelled the market. Liquid biopsy, which utilizes circulating tumor cells and cell-free DNA, has gained popularity as a minimally invasive alternative to traditional tissue biopsies, reducing patient discomfort and enabling real-time monitoring of tumor dynamics.

North America currently dominates the global CTCs market, owing to its well-established healthcare infrastructure, increasing awareness about early cancer detection, and strong investment in research and development. However, the Asia-Pacific region is expected to witness the fastest growth during the forecast period, attributed to a rising cancer burden, improving healthcare systems, and increased adoption of advanced diagnostic technologies.

Key players in the circulating tumor cells market are focusing on research collaborations, product innovations, and mergers and acquisitions to strengthen their market presence and gain a competitive edge.

• Greiner Bio One International GmbH
• Advanced Cell Diagnostics Inc.
• Aviva Biosciences
• Biocept, Inc.
• BioFluidica
• Bio-Techne Corporation
• Creatv Micro Tech Inc.
• Fluxion Biosciences, Inc.
• LungLife AI Inc.
• Menarini Silicon Biosystems
• Miltenyi Biotec
• Precision for Medicine
• QIAGEN
• Rarecells Diagnostics
• ScreenCell
• Sysmex Corporation
• Other Prominent players

𝐑𝐞𝐚𝐝 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐈𝐧𝐝𝐞𝐱 𝐨𝐟 𝐟𝐮𝐥𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐭𝐮𝐝𝐲 𝐚𝐭 @ https://www.astuteanalytica.com/industry-report/circulating-tumor-cells-market

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

𝐁𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲

• CTC Detection & Enrichment Methods
• Advanced CTC Detection Technologies

𝐁𝐲 𝐒𝐩𝐞𝐜𝐢𝐦𝐞𝐧

• Blood
• Bone Marrow
• Other Body Fluids

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

• Kits & Reagents
• Blood Collection Tubes
• Devices or Systems

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

• Clinical/Liquid Biopsy
• Research

𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧

• 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚

o The U.S.
o Canada
o Mexico

• 𝐄𝐮𝐫𝐨𝐩𝐞

o The UK
o Germany
o France
o Spain
o Russia
o Rest of Europe

• 𝐀𝐬𝐢𝐚 𝐏𝐚𝐜𝐢𝐟𝐢𝐜

o China
o India
o Japan
o Australia & New Zealand
o South Korea
o ASEAN
o Rest of Asia Pacific

• 𝐌𝐢𝐝𝐝𝐥𝐞 𝐄𝐚𝐬𝐭 & 𝐀𝐟𝐫𝐢𝐜𝐚 (𝐌𝐄𝐀)

o UAE
o Saudi Arabia
o Rest of MEA

• 𝐒𝐨𝐮𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚

o Argentina
o Brazil
o Rest of South America

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.astuteanalytica.com/request-sample/circulating-tumor-cells-market

𝐀𝐛𝐨𝐮𝐭 𝐀𝐬𝐭𝐮𝐭𝐞 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

𝐆𝐞𝐭 𝐢𝐧 𝐭𝐨𝐮𝐜𝐡 𝐰𝐢𝐭𝐡 𝐮𝐬
𝐏𝐡𝐨𝐧𝐞 𝐧𝐮𝐦𝐛𝐞𝐫: +18884296757
𝐄𝐦𝐚𝐢𝐥: sales@astuteanalytica.com
𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.astuteanalytica.com/
LinkedIn | Twitter | YouTube | Facebook

This release was published on openPR.